Population-Level Trends in Attention-Deficit/Hyperactivity Disorder Medication Prescribing
This cross-sectional study describes changes in prescription rates for attention-deficit/hyperactivity (ADHD) disorder medication in Ontario from 2015 to 2023.
Authors
- Robert Talarico (ORCID: https://orcid.org/0000-0001-5060-680X)
- Daniel T. Myran (ORCID: https://orcid.org/0000-0002-8038-300X)
- Yaron Finkelstein (ORCID: https://orcid.org/0000-0002-0947-3571)
- Rachael MacDonald‐Spracklin (ORCID: https://orcid.org/0000-0002-2016-3232)
- Giovanna Busa
Institutions
- University of Ottawa (CA)
- University of Toronto (CA)
- North York General Hospital (CA)
- Ottawa Hospital (CA)
- Hospital for Sick Children (CA)
- Bruyère (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-12-11
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.48532
- Citations
- 1
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Ontario Ministry of Health and Long-Term Care
- Hospital for Sick Children
- Sickkids Research Institute